US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist
  • 40.150
  • -1.650-3.95%
Close Jul 2 16:00 ET
2.52BMarket Cap-55763P/E (TTM)

MoonLake Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MoonLake Immunotherapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.22

+4.35%
Analyst Rating

Strong Buy

Jul 2, 2024

MoonLake Immunotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

MoonLake Immunotherapeutics Earnings Reports

  • MoonLake Immunotherapeutics | 10-Q: Quarterly report

    May 7 08:04 ET

  • MoonLake Immunotherapeutics | 10-K/A: Annual report (Amendment)

    May 7 07:59 ET

  • MoonLake Immunotherapeutics | 10-K: Annual report

    Feb 29 08:08 ET

  • MoonLake Immunotherapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 08:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 2, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg